Companies / Financials
CBOE
Cboe Global Markets
Financial Exchanges & Data
Financial Exchanges & DataAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health76
Growth61
Profitability87
Cash generationn/a
Balance sheetn/a
Dilution control80
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)19.0%Revenue growth (FY)15.1%Revenue CAGR (3y)6.0%Gross margin51.5%Operating margin31.1%Net margin23.3%Free cash flow margin35.7%R&D / revenue—Stock comp / revenue1.1%Net debt / operating cash flow-0.44xCurrent ratio1.87Diluted share count change-0.4%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $3.5B | $4.0B | $3.8B | $4.1B | $4.7B |
| Gross profit | $1.5B | $1.7B | $1.9B | $2.1B | $2.4B |
| Operating income | $806M | $490M | $1.1B | $1.1B | $1.5B |
| Net income | $529M | $235M | $761M | $765M | $1.1B |
| Operating cash flow | $597M | $651M | $1.1B | $1.1B | $1.8B |
| Capital expenditure | $51M | $60M | $45M | $61M | $71M |
| Free cash flow | $546M | $591M | $1.0B | $1.0B | $1.7B |
| Stock-based comp | $27M | $31M | $41M | $42M | $50M |
| Buybacks | $81M | $101M | $84M | $205M | $67M |
| Dividends | $193M | $209M | $224M | $249M | $284M |
| Cash | $342M | $433M | $543M | $920M | $2.2B |
| Total debt | $1.3B | $2.0B | $1.4B | $1.4B | $1.4B |
| Equity | $3.6B | $3.5B | $4.0B | $4.3B | $5.1B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.